Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant MAID Chemotherapy and Radiation for High-Risk Soft Tissue Sarcoma
NCT00002791Phase 2Completed
- Sponsor
- NRG Oncology
- Start
- Feb 1997
- Primary completion
- May 2002
- Modality
- DNA Intercalators/Alkylators
- Countries
- 3
01
Overview
A Phase 2 trial of doxorubicin, ifosfamide, dacarbazine in soft tissue sarcoma (STS), sponsored by NRG Oncology. Started Feb 1997; status: completed.
02
Drugs
doxorubicinifosfamidedacarbazine
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00002791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002791.